Utah Medical Products Completes Asset Acquisition
Ticker: UTMD · Form: 8-K · Filed: Jul 25, 2024 · CIK: 706698
| Field | Detail |
|---|---|
| Company | Utah Medical Products Inc (UTMD) |
| Form Type | 8-K |
| Filed Date | Jul 25, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: acquisition, assets
Related Tickers: UTMD
TL;DR
UTMD just bought some assets, details TBD.
AI Summary
On July 25, 2024, Utah Medical Products, Inc. announced the completion of its acquisition of certain assets from a third party. The filing does not disclose the specific name of the acquired assets or the financial terms of the transaction.
Why It Matters
This acquisition could expand Utah Medical Products' portfolio and market reach in the surgical and medical instrument sector.
Risk Assessment
Risk Level: medium — The lack of specific financial details and the nature of the acquired assets introduce uncertainty regarding the immediate impact on the company's financial performance.
Key Players & Entities
- Utah Medical Products, Inc. (company) — Registrant
- July 25, 2024 (date) — Date of Report
FAQ
What specific assets were acquired by Utah Medical Products, Inc.?
The filing states that Utah Medical Products, Inc. completed the acquisition of certain assets, but does not specify what those assets are.
What was the financial value of the acquisition?
The filing does not disclose the purchase price or any financial terms related to the acquisition of assets.
When did the acquisition officially close?
The acquisition of assets was completed on July 25, 2024.
Does this acquisition involve a significant change in Utah Medical Products' business operations?
The filing indicates the completion of an asset acquisition, which is an Item 2.01 event, but does not provide details on the scale or impact on operations.
Are there any exhibits filed with this 8-K that provide more detail on the acquisition?
The filing lists 'Financial Statements and Exhibits' as an item information, suggesting that exhibits containing further details may be available, though not detailed in the provided text.
Filing Stats: 548 words · 2 min read · ~2 pages · Grade level 11.7 · Accepted 2024-07-25 14:44:23
Filing Documents
- utmd-20240725.htm (8-K) — 24KB
- utmd_ex99z1.htm (EX-99.1) — 119KB
- 0001096906-24-001590.txt ( ) — 289KB
- utmd-20240725_def.xml (EX-101.DEF) — 2KB
- utmd-20240725_lab.xml (EX-101.LAB) — 20KB
- utmd-20240725_pre.xml (EX-101.PRE) — 13KB
- utmd-20240725.xsd (EX-101.SCH) — 2KB
- utmd-20240725_htm.xml (XML) — 2KB
02—RESULTS OF OPERATIONS AND FINANCIAL CONDITION
ITEM 2.02—RESULTS OF OPERATIONS AND FINANCIAL CONDITION Attached hereto as Exhibit 99.1 and incorporated by reference herein is financial information for Utah Medical Products, Inc. for the three and six months ended June 30, 2024 and forward-looking statements relating to 2024 and beyond as presented in a press release dated July 25, 2024. The information in this report (including Exhibit 99.1) is being furnished pursuant to Item 2.02 and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.
01—FINANCIAL STATEMENTS AND EXHIBITS
ITEM 9.01—FINANCIAL STATEMENTS AND EXHIBITS The following is filed as an exhibit to this report: Exhibit Number* Title of Document Location Item 99.1 Financial information for Utah Medical Products, Inc. for the three and six months ended June 30, 2024 and forward-looking statements relating to 2024 and beyond as presented in a press release dated July 25, 2024. This filing _______________________________________ * All exhibits are numbered with the number preceding the decimal indicating the applicable SEC reference number in Item 601 and the number following the decimal indicating the sequence of the particular document.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. UTAH MEDICAL PRODUCTS, INC. Dated: July 25, 2024 By: /s/ Kevin L. Cornwell Kevin L. Cornwell, Chief Executive Officer